Klacid

Clarithromycin, the active ingredient in Klacid, is a macrolide antibiotic presented as an intravenous solution for intravenous use. It treats a range of bacterial infections, including pneumonia, sinusitis, skin infections, streptococcal pharyngitis, and is part of Helicobacter pylori eradication regimens. GNH USA supplies Klacid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Klacid is a macrolide antibiotic indicated for several bacterial infections. - Community‑acquired pneumonia: eradicates the causative bacteria and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation by eliminating pathogenic organisms. - Skin and soft tissue infections: treats cellulitis and wound infections caused by susceptible bacteria. - Streptococcal pharyngitis: clears streptococcal infection and relieves throat symptoms. - Helicobacter pylori eradication: used in combination therapy to eliminate H. pylori and aid ulcer healing.

Clarithromycin may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools that may be watery. - Abdominal pain: cramping or discomfort in the stomach area. - Altered taste: metallic or bitter sensation. - Headache: mild to moderate pain. - Elevated liver enzymes: mild increase in hepatic transaminases.

Serious or Rare Side Effects: - Severe allergic reactions: rash, swelling, or anaphylaxis. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile‑associated diarrhea: severe colitis. - Hepatotoxicity: significant liver injury. - Stevens‑Johnson syndrome or toxic epidermal necrolysis: severe skin reactions.

Before using Klacid, consider the following precautions. - Renal impairment: assess kidney function and adjust therapy if needed. - Hepatic impairment: monitor liver function tests during treatment. - QT prolongation risk: avoid in patients with known prolonged QT or concurrent QT‑prolonging drugs. - Drug interactions: review concomitant medications for potential interactions. - Pregnancy Category B: use only when the benefit outweighs potential risk. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

Clarithromycin interacts with several medicines; monitoring is essential.

Major Interactions (Avoid): - Erythromycin or other macrolides: additive QT prolongation. - Cisapride: increased risk of serious arrhythmias. - Pimozide: heightened QT prolongation potential. - Theophylline: elevated plasma concentrations leading to toxicity. - Statins (lovastatin, simvastatin): increased risk of myopathy.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR and bleeding risk. - Carbamazepine: may reduce clarithromycin levels. - Rifampin: may decrease clarithromycin efficacy. - Oral contraceptives: potential reduction in contraceptive effectiveness. - Antacids containing aluminum or magnesium: may lower clarithromycin absorption.